相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-kappa B activation
Isabella Faraoni et al.
CANCER LETTERS (2018)
Development and validation of a high-performance liquid chromatography method for the quantitation of intracellular PARP inhibitor Olaparib in cancer cells
Pierre Daumar et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
PARP inhibitors and quality of life in ovarian cancer
Daisuke Aoki et al.
LANCET ONCOLOGY (2018)
Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer
Chia-Hao Liu et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2017)
PARP inhibitors: the race is on
Jessica S. Brown et al.
BRITISH JOURNAL OF CANCER (2016)
Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine
Stephen Murata et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Advances in PARP inhibitors for the treatment of breast cancer
Omer Dizdar et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
PARP inhibitors: A new era of targeted therapy
Shifalika Tangutoori et al.
MATURITAS (2015)
Targeting the DNA Damage Response in Cancer
Mark J. O'Connor
MOLECULAR CELL (2015)
BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib
Robin Dufour et al.
SCIENTIFIC REPORTS (2015)
Inhibition of poly(ADP-ribosyl)ation in cancer: Old and new paradigms revisited
Barbara Lupo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay quantifying vemurafenib in human plasma
C. M. Nijenhuis et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Intracellular Drug Concentrations
C. T. Dollery
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay quantifying olaparib in human plasma
C. M. Nijenhuis et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Mechanisms of resistance to therapies targeting BRCA-mutant cancers
Christopher J. Lord et al.
NATURE MEDICINE (2013)
Mechanisms of Resistance to PARP Inhibitors-Three and Counting
Tito Fojo et al.
CANCER DISCOVERY (2013)
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai et al.
CANCER RESEARCH (2012)
PARP Inhibitor Treatment in Ovarian and Breast Cancer
[Anonymous]
CURRENT PROBLEMS IN CANCER (2011)
Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic
Dana V. Ferraris
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Poly(ADP-ribose):: novel functions for an old molecule
Valerie Schreiber et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
分享论文
